Radiation Therapy Followed by Intrathecal (IT) Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease: Interim Results from a Phase II Multi-Institutional Study

The requested reference [d6ba80187d06656362e4544bfe43e58cc50878b8] no longer exists in our database. It has been replaced by the current reference: [b0a8a94f1620dcd6b184e40428e1d5ed76a3776c]

Authors
Category Primary study
ConferenceSan Antonio Breast Cancer Symposium 2025
Year 2026
This article has no abstract
Epistemonikos ID: 110d0cb60c735847577dc51b16074167728af083
First added on: Jun 06, 2026